Altocor extended-release lovastatin regulatory update

ADRX received an approvable letter from the FDA for its NDA for Altocor lovastatin XL to treat hypercholesterolemia. Altocor, an inhibitor of HMG-CoA reductase, uses ADRX's SCOT controlled-release tec...